Abstract
We describe a patient with the biochemically established combination of Farber and Sandhoff disease. A 6-month-old girl of consanguineous Turkish parents presented with hoarseness, stridor, scattered skin nodules, painful swelling of hand joints and ankles, and cherry-red macular spots. Until the age of 2 years her motor and physical condition deteriorated distinctly, however her mental state remained unchanged. A biopsied skin nodule disclosed lysosomal inclusions within storage cells that were typical of Farber disease (curved tubular structures). However, other inclusions (e.g. zebra bodies) were also found. Biochemical findings included ceramide accumulation in skin nodules and cultured fibroblasts, impaired ceramide degradation on loading of cultured fibroblasts with radioactive sphingomyelin, profoundly decreased ceramidase activity in fibroblasts as well as total β-hexosaminidase activity in fibroblasts and serum, absent hexosaminidase A and B bands on cellogel zymograms, increased urinary oligosaccharide excretion of the Sandhoff disease type, and a partial reduction of ceramidase and total β-hexosaminidase activities in fibroblasts from her father. A diagnosis of combined Farber and Sandhoff disease was made. The effect of both enzyme deficiencies on the clinical manifestations in this patient and the genetic basis of this combination require further studies.
Similar content being viewed by others
References
Bolhuis PA, Oonk JGW, Kamp PE, Ris AJ, Michalski JC, Overdijk B, Reuser AJJ (1987) Ganglioside storage, hexosaminidase lability and urinary oligosaccharides in adult Sandhoff's disease. Neurology 37:75–81
Burck U, Moser HW, Goebel HH, Grüttner R, Held KR (1985) A case of lipogranulomatosis Farber; some clinical and ultrastructural aspects. Eur J Pediatr 143:203–208
Dulaney JT, Milunsky A, Sidbury JB, Hobolth N, Moser HW (1976) Diagnosis of lipogranulomatosis (Farber disease) by use of cultured fibroblasts. J Pediatr 89:59–61
Goebel HH, Stolte G, Kustermann-Kuhn B, Harzer K (1989) B1 variant of GM2 gangliosidosis in a 12 9/12 year old patient. Pediatr Res (accepted for publication)
Kudoh T, Wenger DA (1982) Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts. J Clin Invest 70:89–97
Kustermann-Kuhn B, Harzer K (1983) Prenatal diagnosis of Tay-Sachs disease. Reflectometry of hexosaminidase A, B, and C/S bands on zymograms. Hum Genet 65:172–175
Kytzia H-J, Hinrichs U, Sandhoff K (1984) Diagnosis of infantile and juvenile forms of GM2-gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates. Hum Genet 67:414–418
Moser HW, Chen WW (1983) Ceramidase deficiency: Farber's lipogranulomatosis. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 820–830
Pellissier JF, Berard-Badier M, Pinsard N (1986) Farber's disease in two siblings, sural nerve and subcutaneous biopsies by light and electron microscopy. Acta Neuropathol 72:178–188
Schmoeckel C, Hohlfeld M (1979) A specific ultrastructural marker for disseminated lipogranulomatosis (Farber). Arch Dermatol Res 266:187–196
Sewell AC (1979) An improved thin layer chromatographic method for urinary oligosaccharide screening. Clin Chim Acta 92:411–414
Zarbin MA, Green WR, Moser HW, Morton SJ (1985) Farber's Disease. Light and electron microscopy study of the eye. Arch Ophthalmol 103:73–80
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fusch, C., Huenges, R., Moser, H.W. et al. A case of combined Farber and Sandhoff disease. Eur J Pediatr 148, 558–562 (1989). https://doi.org/10.1007/BF00441558
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441558